Javascript must be enabled to continue!
Insights into Community Experiences with Research License Review Across Nunavut
View through CrossRef
Nunavut is one of the three northern territories in Canada. Under Nunavut’s Scientists Act, the Nunavut Research Institute (NRI) administers research licenses in the territory. The research license review (RLR) process includes community organizations in reviewing applications, ensuring Nunavummiut (people of Nunavut) priorities are considered. RLR organizations can recommend approval, rejection, or conditions for research licenses. To better understand RLR organizations’ experience with the NRI’s research licensing process, we undertook a survey to learn about: i) the annual volume of RLR requests; ii) RLR organizations’ review protocols and practices; iii) opportunities and challenges associated with RLR; and iv) recommendations for improving the NRI’s consultation process. Survey results showed that RLR organizations receive up to 64 applications annually, with most (40%) receiving one to 10 applications per year. Over half (55%) of RLR organizations review all applications received. Some (35%) reviewers are financially compensated for time spent reviewing, and 45% of organizations assign different reviewers for each application. Only 10% of reviewers provide feedback for all applications reviewed. Reviewers reported a need for increased community support and resources for the RLR process, more direct engagement with researchers, and improved access to research outcomes and reports. This survey is the first time Nunavut RLR organizations were consulted on their experiences with the license review process. Their feedback is critical in refining RLR administrative processes, strengthening community – researcher communications, and informing the NRI’s efforts to ensure research is more accessible to Nunavummiut. Taken together, improvements in the RLR process can contribute to enhancing Inuit self-determination in Nunavut research.
The Arctic Institute of North America
Title: Insights into Community Experiences with Research License Review Across Nunavut
Description:
Nunavut is one of the three northern territories in Canada.
Under Nunavut’s Scientists Act, the Nunavut Research Institute (NRI) administers research licenses in the territory.
The research license review (RLR) process includes community organizations in reviewing applications, ensuring Nunavummiut (people of Nunavut) priorities are considered.
RLR organizations can recommend approval, rejection, or conditions for research licenses.
To better understand RLR organizations’ experience with the NRI’s research licensing process, we undertook a survey to learn about: i) the annual volume of RLR requests; ii) RLR organizations’ review protocols and practices; iii) opportunities and challenges associated with RLR; and iv) recommendations for improving the NRI’s consultation process.
Survey results showed that RLR organizations receive up to 64 applications annually, with most (40%) receiving one to 10 applications per year.
Over half (55%) of RLR organizations review all applications received.
Some (35%) reviewers are financially compensated for time spent reviewing, and 45% of organizations assign different reviewers for each application.
Only 10% of reviewers provide feedback for all applications reviewed.
Reviewers reported a need for increased community support and resources for the RLR process, more direct engagement with researchers, and improved access to research outcomes and reports.
This survey is the first time Nunavut RLR organizations were consulted on their experiences with the license review process.
Their feedback is critical in refining RLR administrative processes, strengthening community – researcher communications, and informing the NRI’s efforts to ensure research is more accessible to Nunavummiut.
Taken together, improvements in the RLR process can contribute to enhancing Inuit self-determination in Nunavut research.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Finding Points of Resonance: Nunavut Students’ Perspectives on Science
Finding Points of Resonance: Nunavut Students’ Perspectives on Science
Still largely based on EuroCanadian knowledge and Western teachings, Education in Nunavut remains a negative experience for many Nunavut youth as the result of culturally inappropr...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
What is happening where? An evaluation of social sciences research trends in Nunavut (2004–2019)
What is happening where? An evaluation of social sciences research trends in Nunavut (2004–2019)
Research licensing administered by the Nunavut Research Institute (NRI) affords Nunavummiut (people of Nunavut) an opportunity to engage in research. The NRI partnered with researc...
UPAYA SATLANTAS POLRESTA PALANGKA RAYA DALAM MENCEGAH PEMALSUAN USIA OLEH PEMOHON PENERBITAN SIM C
UPAYA SATLANTAS POLRESTA PALANGKA RAYA DALAM MENCEGAH PEMALSUAN USIA OLEH PEMOHON PENERBITAN SIM C
To be able to have a driver's license for drivers of various types of vehicles must meet the conditions that have been set. Similarly, with driver's license C, one of the conditio...
Good Governance of Food Security in Nunavut
Good Governance of Food Security in Nunavut
Food insecurity is not a new issue in Nunavut, Canada, but it is one that is not yet resolved. In Nunavut, the Government of Canada primarily through Indigenous and Northern Affair...

